Differential expression of Kv1.3 and Kv1.5 voltage-dependent K + channels in human skeletal muscle sarcomas

Cancer Investigation

Volumn 30, Issue 3, 2012, Pages 203-208

  Bielanska, Joanna ^a   Hernández Losa, Javier ^b   Moline, Teresa ^b   Somoza, Rosa ^b   Ramón Y Cajal, Santiago ^b   Condom, Enric ^c   Ferreres, Joan Carles ^b   Felipe, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Alveolar rhabdomyosarcomas; Cancer; Embryonal rhabdomyosarcomas; Potassium channels; Skeletal muscle

Indexed keywords

ALPHA ACTIN; DESMIN; KI 67 ANTIGEN; MYOD1 PROTEIN; MYOGENIN; POTASSIUM CHANNEL KV1.3; POTASSIUM CHANNEL KV1.5; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENICITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; SCHOOL CHILD; SCORING SYSTEM; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; G1 PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; KV1.3 POTASSIUM CHANNEL; KV1.5 POTASSIUM CHANNEL; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RHABDOMYOSARCOMA;

EID: 84857618618     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.654872     Document Type: Article

References (28)

1. Hille B. Ion Channels of Excitable Membranes, 3rd edition. Sunderland, MA: Sinauer, 2001;xviii:814.
2. Conti M. Targeting K+ channels for cancer therapy. J Exp Ther Oncol 2004;4:161-166.
3. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez- Marmol R, Sole L, Ferreres JC, Condom, E. Potassium channels: new targets in cancer therapy. Cancer Detect Prev 2006;30:375-385. (Pubitemid 44402898)
4. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205:159-173. (Pubitemid 41803693)
5. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004;19:285-292. (Pubitemid 39472640)
6. Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membr Biol 1996;154:91-107.
7. Vicente R, Escalada A, Villalonga N, Texido L, Roura-Ferrer M, Martin-Satue M, Lopez-Iglesias C, Soler C, Solsona C, Tamkun MM, Felipe A. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J Biol Chem 2006;281:37675-37685. (Pubitemid 46042071)
8. Villalonga N, Martinez-Marmol R, Roura-Ferrer M, David M, Valenzuela C, Soler C, Felipe A. Cell cycle-dependent expression of Kv1.5 is involved in myoblast proliferation. Biochim Biophys Acta. 2008;1783:728-736.
9. Swanson R,Marshall J, Jeffrey S, Smith JS,Williams JB, Boyle MB, FolanderK,LuneauCJ, Antanavage J,OlivaC,BuhrowSA, Bennet C, Stein RB, Kaczmarek LK. Cloning and expression of cDNA and genomic clones encoding three delayed rectifier potassium channels in rat brain. Neuron 1990;4:929-939. (Pubitemid 20208519)
10. Bielanska J, Hernandez-Losa J, Perez-Verdaguer M,Moline T, Somoza R, Ramon YCS, Condom E, Ferreres JC, Felipe A. Voltagedependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets 2009;9:904-914.
11. Cheong A, Li J, Sukumar P, Kumar B, Zeng F, Riches K, Munsch C, Wood IC, Porter KE, Beech DJ. Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by KV1.3 channel blockers. Cardiovasc Res 2011;89:282-289.
12. Cidad P, Moreno-Dominguez A, Novensa L, Roque M, Barquin L, Heras M, Perez-Garcia MT, Lopez-Lopez JR. Characterization of ion channels involved in the proliferative response of femoral artery smooth muscle cells. Arterioscler Thromb Vasc Biol 2010;30:1203-1211.
13. Vicente R, Escalada A, Coma M, Fuster G, Sanchez-Tillo E, Lopez-Iglesias C, Soler C, Solsona C, Celada A, Felipe A. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem 2003;278:46307-46320. (Pubitemid 37452201)
14. Villalonga N, Escalada A, Vicente R, Sanchez-Tillo E, Celada A, Solsona C, Felipe A. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages. Biochem Biophys Res Commun 2007;352:913-918. (Pubitemid 44894372)
15. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-352.
16. Qualman SJ, Coffin CM, NewtonWA, Hojo H, Triche TJ, Parham DM,CristWM. Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr Dev Pathol 1998;1:550-561.
17. Bielanska J, Hernandez-Losa J, Moline T, Somoza R, RamonYCS, Condom E, Ferreres JC, Felipe A. Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human fetus. Cell Physiol Biochem 2010;26:219-226.
18. LanM, ShiY,HanZ, HaoZ,PanY, LiuN,GuoC, Hong L,Wang J, Qiao T, Fan D. Expression of delayed rectifier potassiumchannels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol Ther 2005;4:1342-1347. (Pubitemid 43131178)
19. Castellvi J, Garcia A, Ruiz-Marcellan C, Hernandez-Losa J, Peg V, Salcedo M, Gil-Moreno A, Ramon y Cajal S. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis. Hum Pathol 2009;40:1418-1426.
20. Felipe A, Snyders DJ, Deal KK, Tamkun MM. Influence of cloned voltage-gated K+ channel expression on alanine transport, Rb+ uptake, and cell volume. Am J Physiol 1993;265:C1230-C1238.
21. Davies AM, Batchelor TJ, Eardley I, Beech DJ. Potassium channel KV alpha1 subunit expression and function in human detrusor muscle. J Urol 2002;167:1881-1886. (Pubitemid 34240775)
22. Xu J, Wang P, Li Y, Li G, Kaczmarek LK, Wu Y, Koni PA, Flavell RA, Desir GV. The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc Natl Acad Sci USA 2004;101:3112-3117. (Pubitemid 38327743)
23. Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 1997;71:165-207.
24. Juuti A, Nordling S, Louhimo J, Lundin J, von Boguslawski K, Haglund C. Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer. Oncology 2003;65:371-377. (Pubitemid 38064950)
25. Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder. Mol Pathol 2003;56:353-361. (Pubitemid 37521929)
26. Miyachi M, Kakazu N, Yagyu S, Katsumi Y, Tsubai-Shimizu S, Kikuchi K, Tsuchiya K, Iehara T, Hosoi H. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res 2009;15:4077-4084.
27. Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG. p57KIP2: "Kip"ing the cell under control. Mol Cancer Res 2009;7:1902-1919.
28. Renaudo A,Watry V, Chassot AA, Ponzio G, Ehrenfeld J, Soriani O. Inhibition of tumor cell proliferation by sigma ligands is associated with K+ Channel inhibition and p27kip1 accumulation. J Pharmacol Exp Ther 2004;311:1105-1114. (Pubitemid 39612717)